Takara Bio Stock

Takara Bio Intangible Assets

Delisted·Jun 12, 2026

The Intangible Assets of Takara Bio (4974.T) as of Aug 24, 2026 is 1.46 B JPY. In the previous year, Intangible Assets was 1.54 B JPY — a change of -5.46% (lower).

Intangible Assets

1.46 BJPY

YoY

-5.46%

Last updated:

Intangible Assets of Takara Bio is 2026 1.46 B JPY. Intangible Assets of Takara Bio was 2025 1.54 B JPY. It decreases by -5.46% lower compared to the previous year.

The Takara Bio Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2018
5.90 B JPY
Jan 1, 2019
5.03 B JPY
Jan 1, 2020
4.35 B JPY
Jan 1, 2021
3.22 B JPY
Jan 1, 2022
2.85 B JPY
Jan 1, 2023
2.37 B JPY
Jan 1, 2024
1.54 B JPY
Jan 1, 2025
1.46 B JPY
The Takara Bio Intangible Assets history
YEARIntangible AssetsYoY
1.46 BJPY-5.46%
1.54 BJPY-35.15%
2.37 BJPY-16.74%
2.85 BJPY-11.60%
3.22 BJPY-25.87%
4.35 BJPY-13.54%
5.03 BJPY-14.80%
5.90 BJPY+442.65%
1.09 BJPY+3.23%
1.05 BJPY-8.90%
1.16 BJPY+4.23%
1.11 BJPY—
Access this data via the Eulerpool API
Get Free API Key

Takara Bio Stock analysis

What does Takara Bio do? Takara Bio Inc is a Japanese biotechnology company that has been active in the medical and life science industry since its founding in 1967. The company is a strong player in the field of molecular biology and operates in several countries such as the USA, Europe, and Asia. Takara Bio Inc was established as an independent company in 1999, focusing exclusively on the production of molecular biology products. The company offers a wide range of products in the fields of research and diagnostics, including enzymes, PCR kits, vectors and plasmids, antibodies, proteins, and cell culture products. Takara Bio Inc is organized into two divisions: Life Science Research and Diagnostics. The Life Science Research division provides products and solutions for research and development in areas such as molecular biology, neuroscience, proteomics, and genomics. The Diagnostics division offers products and solutions for clinical diagnostics and drug development. Takara Bio Inc also specializes in the automation of molecular biology procedures and offers automated systems that can perform processes such as nucleic acid extraction, PCR, and sequencing. The company is committed to sustainability and environmental protection, adhering to strict environmental and quality standards in its production processes and implementing waste reduction and efficient resource utilization programs. Overall, Takara Bio Inc is a leading company in the field of molecular biology, offering a wide range of products and solutions for research and diagnostics, and has become a key player in the life science industry through its global expansion and ability to provide custom solutions. Takara Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Takara Bio stock

Intangible Assets of Takara Bio is 1.46 B JPY in 2026.

Intangible Assets of Takara Bio changed from 1.54 B JPY to 1.46 B JPY, representing a -5.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Takara Bio since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Takara Bio historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Takara Bio

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Takara Bio